Dipna Pharmachem Peer Comparison

BSE: 543594

₹3.93

₹-0.12 (-2.96%)

As on 22-Oct-2026IST

Market cap

₹10 Cr

Revenue (TTM)

₹125 Cr

P/E Ratio

3.9

P/B Ratio

0.2

Div. Yield

0 %

Edit

	Dipna Pharmachem	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Market cap (₹ Cr)	10	30,142	25,728	26,301	23,867
Revenue (₹ Cr)	125	3,564	9,205	1,462	1,936
Net Profit (₹ Cr)	0.97	414.00	-371.81	387.35	288.22
Net Margin (%)	0.78	11.23	-3.93	26.01	14.79
RoE (%)	2.56	8.38	-3.85	25.18	29.77
Price to Earnings	3.90	73.70	--	68.10	82.81
Price-To-Book	0.23	5.99	3.21	15.24	17.78

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Dipna Pharmachem	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Operating Revenue	124.92	3,012.00	9,151.18	1,006.88	1,284.27
Total Income	124.93	3,074.00	9,312.95	1,023.80	1,296.22
Total Expenditure	121.00	2,619.00	7,733.31	774.80	1,028.33
EBITDA	3.92	393.00	1,417.87	232.07	255.95
Depreciation	0.01	217.00	816.34	26.62	36.59
EBIT	3.91	176.00	601.53	205.45	219.36
Interest	2.50	254.00	421.59	6.22	36.78
Other Income	0.01	62.00	161.77	16.93	11.95
Exceptional Items	--	--	--	--	--
Profit before Tax	1.42	-16.00	414.64	216.16	194.52
Provision for Tax	0.45	41.00	323.51	55.75	60.16
Profit after Tax	0.97	-57.00	91.13	160.42	134.36

Liabilities (₹ Cr)

	Dipna Pharmachem	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Shareholder's Funds	38.49	4,353.00	8,125.47	1,309.63	540.98
Minority Interest	--	304.00	--	10.45	0.00
Non-Current Liabilities	8.89	887.00	3,392.72	26.93	122.65
Current Liabilities	85.00	2,042.00	3,850.56	202.25	786.03
Total Liabilities	132.38	8,100.00	15,513.53	1,549.26	1,451.43

Assets (₹ Cr)

	Dipna Pharmachem	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Non-Current Assets	0.05	5,017.00	9,487.47	757.63	386.29
Current Assets	132.33	2,465.00	5,881.28	791.64	1,063.37
Total Assets	132.38	8,100.00	15,513.53	1,549.26	1,451.43
Total Debt*	17.22	1,859.00	4,720.27	8.18	393.17
Net Current Assets	47.33	423.00	2,030.72	589.39	277.34
Contingent Liabilities	--	770.26	99.76	15.38	12.25

Cashflow (₹ Cr)

	Dipna Pharmachem	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Cash From Operating Activities	-9.19	-22.00	892.30	118.34	159.18
Cash Flow from Investing Activities	-0.02	-783.00	-477.46	-223.94	-64.81
Cash from Financing Activities	-4.24	409.00	-440.83	261.12	-39.81
Net Cash Inflow / Outflow	-13.45	-396.00	-25.99	155.52	54.56

Ratios

Profitability Ratios

	Dipna Pharmachem	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
ROCE (%)	6.95	4.07	6.61	20.14	26.97
ROE (%)	2.56	-1.48	1.14	16.19	30.68
ROA (%)	0.73	-0.78	0.60	12.13	10.50
EBIT Margin (%)	3.15	15.11	17.26	24.73	20.86
Net Margin (%)	0.78	-1.85	0.98	15.67	10.37
Cash Profit Margin (%)	0.79	4.14	8.54	18.58	7.13

Growth Ratios

	Dipna Pharmachem	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Revenue Growth (%)	-23.99	7.65	11.99	40.34	50.40
EBIT Growth (%)	12.02	272.95	15.16	83.12	54.77
Net Profit Growth (%)	-10.25	87.92	411.39	229.35	47.63
EPS Growth (%)	-10.26	90.35	410.84	67.16	45.69
Book Value Growth (%)	2.60	29.77	2.28	94.96	42.49

Valuation Ratios

	Dipna Pharmachem	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Price / Earnings	35.30	0.00	326.26	62.97	0.00
Price / Book Value	0.89	5.31	3.69	15.26	0.00
Dividend Yield (%)	0.00	0.00	0.06	0.06	--
EV/EBITDA	13.02	54.36	21.49	79.31	1.09
Market Cap (₹ Cr)	34.39	23,064.69	29,731.27	19,988.69	0.00

Solvency Ratios

	Dipna Pharmachem	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Debt to Equity	0.45	0.43	0.59	0.01	0.76
Short term debt to equity ratio	0.22	0.11	0.12	0.01	0.54
Current Ratio	1.56	1.21	1.53	3.91	1.35
Quick Ratio	1.23	0.85	0.93	3.02	0.69
Interest Coverage	1.57	0.94	1.98	35.76	6.29

Operating Efficiency Ratios

	Dipna Pharmachem	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Debtors to sales (%)	37.05	21.95	25.67	28.85	25.21
Asset Turnover	0.94	0.53	0.70	0.76	1.87
Receivable days	112.80	60.36	77.05	90.06	47.59
Inventory Days	94.70	64.42	77.13	61.02	62.58
Payable days	241.13	218.94	173.49	96.06	228.78
Cash Conversion Cycle	-33.63	-94.15	-19.30	55.02	-118.62

Annual
Quarterly